FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 12a-16 or 15d-16 of
the Securities Exchange Act of 1934
October 27, 1998
Commission File No. 0-26498
NUR MACROPRINTERS LTD.
(Exact Name of Registrant as specified in its Charter)
Not Applicable
(Translation of Registrant's Name into English)
5 David Navon Street
Moshav Magshimim
56910 Israel
(Address and principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports
under cover Form 20-F or Form 40-F.
Form 20-F [X] Form 40-F [ ]
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes [ ] No [X]
If "Yes" is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b).
<PAGE>
Attached hereto and incorporated by reference herein is a press
release of the registrant dated October 27, 1998.
Page 2 of 4
<PAGE>
COMPANY CONTACT: INVESTOR CONTACT:
Erez Shachar, President & Chief Executive Officer Jody Burfening (ext. 304)
Eitan Padan, Chief Financial Officer Lippert/Heilshorn & Assoc.
NUR Macroprinters Ltd. 212-838-3777
011-972-3-908-7676 [email protected]
E-mail: [email protected]
NUR MACROPRINTERS FILES REGISTRATION STATEMENT
ON BEHALF OF CERTAIN SECURITY HOLDERS
Magshimim, Israel - October 27, 1998 - NUR Macroprinters Ltd.
(NASDAQ-NMS Symbol: NURTF) ("Nur"), announced today the filing of a registration
statement on behalf of certain security holders for the proposed sale by such
security holders of 5,897,339 Ordinary Shares of Nur, NIS 1.0 par value,
including 555,000 shares underlying warrants, and 1,342,339 shares underlying
options, issued by Nur. Nur will not receive any proceeds from the sale of such
securities. Such sales are anticipated to be made by such security holders from
time to time after the effective date of the registration statement at
negotiated or prevailing market prices. A copy of the prospectus can be obtained
through Eitan Padan, Chief Financial Officer of Nur, at the offices of Nur at 5
David Navon Street, Moshav Magshimim 56910, Israel, 971-3-908-7676.
The registration statement related to these securities has been filed
with the Securities Exchange Commission but has not yet become effective. Such
securities may not be sold nor may offers to buy be accepted prior to the time
the registration statement becomes effective. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy nor shall
there be any sale of these securities in any state or other jurisdiction in
which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such jurisdiction.
NUR Macroprinters Ltd. is a world leader in the development,
manufacturing, marketing and servicing of wide-format ink-jet printing systems
and consumables. Nur's printers are marketed principally to commercial printers,
media companies, and screen printers for a variety of large format applications,
such as billboards, posters, banners and point of purchase displays for
advertising as well as decorations and backdrops for show rooms, fleet graphics,
trade shows, museums and exhibits. NUR's printers are installed in over 140
sites throughout Europe, North and South America, Africa and Asia.
Certain statements made herein that use the words "estimate" "project"
"intend'" "expect'" "believe" and similar expressions are intended to identify
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements involve known
and unknown risks and uncertainties which could cause the actual results,
performance or achievements of Nur to be materially different from those which
may be expressed or implied by such statements, including, among others, changes
in general economic and business conditions and specifically, decline in demand
to Nur's products, inability to timely develop and introduce new technologies,
products and applications and loss of market share and pressure on prices
resulting from competition. For additional information regarding these and other
risks and uncertainties associated with Nur's business, reference is made to
Nur's reports filed from time to time with the Securities and Exchange
Commission.
###
Page 3 of 4
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
NUR MACROPRINTERS LTD.
Date: October 27, 1998 By: /s/ Erez Shachar
---------------------------
Name: Erez Shachar
Title: Chief Executive Officer
Page 4 of 4
